Live Quote · NASDAQVYNEHealthcare· Biotechnology

VYNE Therapeutics Inc.

$28.56▲ 0.00%(+$0.00)
MKT CAP $19.07MLAST EARNINGS Aug 13, 2026
50%
Bullish
TickerSpark Score
64/100
▌ Mixed
75
Valuation
40
Profitability
90
Growth
84
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a VYNE research report →

Analyst Price Target
$5.75-79.9% vs. today

Range $5.75 – $5.75

Analyst RatingBuy
1 Buy1 Hold0 Sell

Price Chart

-60.88% · this period
$73.00$43.67$14.35Jul 25Jan 26Jul 27
52-Week Range24% of range
Low
$14.03
Current
$28.56
High
$74.47